Skip to main content
. 2021 Aug 21;38(Suppl 2):52–60. doi: 10.1007/s12325-021-01860-1

Fig. 1.

Fig. 1

Mean change between baseline and 12 weeks in Hamilton Anxiety Rating Scale (HAM-A) in a randomised trial comparing agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in the treatment of generalised anxiety disorder [32]. Error bars represent standard deviation. ‘Severe anxiety’ was defined as patients with a HAM-A total score ≥ 25 and a CGI-S (Clinical Global Impression–Severity scale) rating ≥ 5 at baseline